封面
市場調查報告書
商品編碼
1410790

美容注射市場:市場規模(按細分市場)、份額、法律法規、報銷、程序、預測(截至2033年)

Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

注射美容是指將凝膠狀物質注射到皮下以恢復更年輕的外觀。這可以透過增加凹陷的臉頰和太陽穴的體積、減少鼻子和嘴巴周圍的皺紋(木偶紋或微笑紋)、豐滿嘴唇和強調面部輪廓來實現。美容注射變得越來越流行,因為它們是非手術且非侵入性的。

此外,可以在有限的恢復時間內快速取得成功的結果。隨著美容注射劑市場的成長,外科醫生可用的注射填充劑的數量和類型不斷增加。

該報告深入探討了全球注射美容市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。

目錄

目前註射美容市場及競爭狀況

  • 洞察關鍵產業趨勢
  • 2015年至2033年美容注射各細分市場總收入及市場前景
  • 按細分市場劃分的程序總數、單位數、平均售價和市場價值的詳細數據

全球、區域和國家見解

  • 美容注射市場SWOT分析
  • 美容注射市場的競爭動態洞察與趨勢
  • 按國家/地區劃分的醫療保健系統概覽
  • 各國報銷政策
  • 各國醫療技術法規現狀

Abstract

Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Aesthetic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Aesthetic Injectables market for the year 2020 and beyond. Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are rising in popularity, due to the non-surgical and non-invasive nature of these procedures.

In addition, successful outcomes are achieved quickly with limited recovery time. As the aesthetic injectables market grows, the number and variety of injectable fillers available to surgeons is increasing.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Aesthetic Injectables and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Aesthetic Injectables market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights -

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Aesthetic Injectables market.
  • Competitive dynamics insights and trends provided for the Aesthetic Injectables market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KgaA, Huadong Medicine Co Ltd, Teoxane SA, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Aesthetic Injectables marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Aesthetic Injectables market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Aesthetic Injectables market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Aesthetic Injectables market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Aesthetic Injectables market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable